Henry Ji

Henry H.
Ji was the founder of Sorrento Therapeutics, Inc., founded in 1989, serving as Chairman, President & Chief Executive Officer since 2017 and currently as Director & Chief Scientific Officer.
Dr. Ji is the founder of BioVintage, Inc., founded in 2002, serving as President since 2002.
Dr. Ji was the founder of Stratagene Genomics, Inc., founded in 1997, serving as President, Chief Executive Officer & Director from 1997 to 1999.
Dr. Ji currently serves as Chief Executive Officer & Chief Financial Officer at Scintilla Pharmaceuticals, Inc. Dr. Ji currently serves as Executive Chairman, President & CEO at Semnur Pharmaceuticals, Inc. starting 2026.
Dr. Ji currently serves as Chief Executive Officer & Secretary at Semnur, Inc. since 2013.
Dr. Ji currently serves as Executive Chairman, President & CEO at Scilex Holding Co. starting 2025.
Dr. Ji currently serves as Chief Executive Officer at Oqory, Inc. Dr. Ji currently serves as Director at Scilex Pharmaceuticals, Inc. since 2019.
Dr. Ji currently serves as Director at Elsie Biotechnologies Inc. Dr. Ji currently serves as Director at JP 3E Holdings, Inc. starting 2026.
Former positions include Executive Chairman at Scilex, Inc. from 2019 to 2022; Executive Chairman at Scilex Holding Co. from 2019 to 2023; Director at NantKwest, Inc. from 2014 to 2015; Director-Business Development at Stratagene Corp.
from 1999 to 2001; Managing Director at Hongye SD Group LLC; Director at Celularity, Inc. (United States) from 2017 to 2021; Vice President at CombiMatrix Corp.
from 2001 to 2002; Secretary & Chief Scientific Officer at Quikbyte Software, Inc. in 2009.
Education includes a doctorate from the University of Minnesota and an undergraduate degree from Fudan University.